Treatment Choices and Mortality in RA-ILD Save
Dr. Julian Segan talks with Dr. Bryant England about abstract 0245 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0245: Influence of Forced Vital Capacity Impairment on Treatment Selection and Outcomes in RA-ILD Patients Initiating a Biologic or Targeted-Synthetic DMARD
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.